Brian Magierski

Brian is founder and CEO of 21Impact, which develops digital health applications to put people in control of extending and elevating their own peak brain performance – and is the first company to commercialize our science through a soon-to-be-announced platform called xponetiq.

Brian is a global entrepreneur in blockchain, mobile and internet-based software and healthy lifestyle service businesses in the United States, Europe and Asia. Through the years, he has been a part of teams that raised hundreds of millions of dollars in private equity funding from global investors and led the purchase and sale of several global enterprises.

Brian holds a BS from Cornell in Engineering and an MBA from Harvard Business School.